Alpa Laboratories Limited
NSE:ALPA.NS
Overview | Financials
Company Name | Alpa Laboratories Limited |
Symbol | ALPA.NS |
Currency | INR |
Price | 110.28 |
Market Cap | 2,320,357,368 |
Dividend Yield | 0% |
52-week-range | 69.9 - 144.5 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Mahendra Singh Chawla |
Website | https://www.alpalabs.in |
An error occurred while fetching data.
About Alpa Laboratories Limited
Alpa Laboratories Limited engages in manufacturing, marketing, and selling pharmaceutical finished dosage forms in India. It offers ethical, generic, and over the counter products in various finished dosage forms, including injections, tablets, capsules, eye and ear drops, ointments, creams, and gels for human use; and boluses, injections, and intra-mammary infusions
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD